胃肠道微生物组在类风湿关节炎、银屑病关节炎、强直性脊柱炎和反应性关节炎中的作用:一项系统综述
本系统综述基于Cochrane指南方法并按照PRISMA标准报告,检索截至2024年8月的多个数据库,纳入比较类风湿关节炎、强直性脊柱炎、银屑病关节炎或反应性关节炎患者与对照者通过16s rRNA或鸟枪法测序评估微生物组的研究,共纳入53项类风湿关节炎研究、34项强直性脊柱炎研究、6项银屑病关节炎研究和2项反应性关节炎研究;疾病组和疾病活动度较高的患者中观察到多样性降低;现有横断面研究提示疾病状态与对照者相比微生物组发生改变;关于微生物组在炎症性关节炎中作用的纵向研究有限,尤其是银屑病关节炎;需要进一步研究以了解微生物组作为生物标志物用于更好地理解预后和制定个体化治疗的效用。
要点
- 疾病组和疾病活动度较高的患者中观察到微生物组多样性降低。
- 现有横断面研究提示疾病状态与对照者相比微生物组发生改变。
- 关于微生物组在炎症性关节炎中作用的纵向研究有限,尤其是银屑病关节炎。
核心结论
- 关于微生物组在炎症性关节炎中作用的纵向研究有限,尤其是银屑病关节炎。
- 现有横断面研究提示疾病状态与对照者相比微生物组发生改变。
- 需要进一步研究以了解微生物组作为生物标志物用于更好地理解预后和制定个体化治疗的效用。
研究设计与样本
- 本系统综述基于Cochrane指南方法进行,并按照PRISMA标准报告。
- 检索截至2024年8月的PubMed、Medline、ScienceDirect、Scopus、Web of Science、Cochrane、EMBASE和CINAHL数据库。
- 纳入通过16s rRNA或鸟枪法测序比较类风湿关节炎、强直性脊柱炎、银屑病关节炎或反应性关节炎患者与对照者微生物组的研究。
- 所有参考文献由两名评价者系统评估,研究质量采用纽卡斯尔-渥太华量表评价。
- 共纳入53项类风湿关节炎研究、34项强直性脊柱炎研究、6项银屑病关节炎研究和2项反应性关节炎研究。
主要发现
- 检索共得到25,794条结果,其中纳入类风湿关节炎组53项研究、强直性脊柱炎组34项研究、银屑病关节炎组6项研究和反应性关节炎组2项研究。
- 在疾病组和疾病活动度较高的患者中观察到多样性降低。
- 现有横断面研究提示疾病状态与对照者相比微生物组发生改变。
关键数值与推荐
- 感兴趣的结果包括α多样性和β多样性、微生物的丰度或耗竭以及功能分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 关于微生物组在炎症性关节炎中作用的纵向研究有限,尤其是银屑病关节炎。
- 需要进一步研究以了解微生物组作为生物标志物用于更好地理解预后和制定个体化治疗的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an increasing body of literature observing a state of dysbiosis in the gut microbiome in different autoimmune conditions including inflammatory arthritis. It is unknown whether the microbiome can be a biomarker for prognostication purposes or for stratification of treatment strategies. This review aims to evaluate the existing evidence on the association between the microbiome and inflammatory arthritis, including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) and reactive arthritis (ReA) population groups. METHODS: This systematic review was performed based on methods from the Cochrane guidelines and reported based on PRISMA criteria. Studies exploring the microbiome of patients with RA, AS, PsA or ReA compared with controls via 16s rRNA or shotgun sequencing were evaluated. The outcomes of interest include alpha and beta diversity, abundance or depletion of organisms and functional analysis. Literature up to August 2024 was retrieved searching the databases PubMed, Medline, ScienceDirect, Scopus, Web of Science, Cochrane, EMBASE and CINAHL. All references were systematically evaluated by two reviewers. Quality of the studies were evaluated by the Newcastle-Ottawa Scale. FINDINGS: The review yielded 25,794 search results, of which 53 studies were included for the RA group, 34 studies for the AS group, 6 studies for the PsA group and 2 studies for the ReA group. Reduced diversity has been observed in disease groups and in patients with higher disease activity. INTERPRETATION: There are limited longitudinal studies on the role of the microbiome in inflammatory arthritis, in particular PsA. Existing cross-sectional studies suggest altered microbiome in disease states compared with controls. Further studies are required to understand the utility of the microbiome as a biomarker to better understand prognosis and tailor treatments.
引用
- Ng BCK, Lassere M. The role of the gastrointestinal microbiome on rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and reactive arthritis: A systematic review. Semin Arthritis Rheum. 2024. PMID: 39644691. doi:10.1016/j.semarthrit.2024.152574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。